Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Force

Showing results (11-20 of 105) with videos related to

Pageof 11
Sort By:
Progress in Cardiovascular Diseases|August 24, 2010
Why do kinase inhibitors cause cardiotoxicity and what can be done about it?Hui Cheng, Thomas Force
The Journal of Biological Chemistry|December 10, 2008
Unique and overlapping functions of GSK-3 isoforms in cell differentiation and proliferation and cardiovascular developmentThomas Force, James R Woodgett
Journal of Cardiac Failure|February 28, 2006
The year in heart failure 2005Barry M Massie, Thomas Force
Nature Reviews. Drug Discovery|February 2, 2011
Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomesThomas Force, Kyle L Kolaja
The Journal of Clinical Investigation|March 15, 2005
Protein kinase cascades in the regulation of cardiac hypertrophyGerald W Dorn, Thomas Force
Trends in Cardiovascular Medicine|April 10, 2007
Glycogen synthase kinase-3beta -- actively inhibiting hypertrophyRisto Kerkelä, Kathleen Woulfe, Thomas Force
Cell Cycle (Georgetown, Tex.)|October 13, 2006
Activation of beta-catenin signaling pathways by classical G-protein-coupled receptors: mechanisms and consequences in cycling and non-cycling cellsSergey P Shevtsov, Syed Haq, Thomas Force
Physiological Reviews|October 21, 2010
Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking taleBeth A Rose, Thomas Force, Yibin Wang
Journal of the American College of Cardiology|March 19, 2004
Highlights of the 2003 scientific sessions of the Heart Failure Society of America; Las Vegas, Nevada, September 21 to 24, 2003Peter Liu, Marvin A Konstam, Thomas Force
Journal of the American College of Cardiology|January 19, 2013
Cancer genetics and the cardiotoxicity of the therapeuticsHind Lal, Kyle L Kolaja, Thomas Force
Pageof 11

Showing results (11-20 of 105) with videos related to

Sort By:
Pageof 11
Progress in Cardiovascular Diseases|August 24, 2010
Why do kinase inhibitors cause cardiotoxicity and what can be done about it?Hui Cheng, Thomas Force
The Journal of Biological Chemistry|December 10, 2008
Unique and overlapping functions of GSK-3 isoforms in cell differentiation and proliferation and cardiovascular developmentThomas Force, James R Woodgett
Journal of Cardiac Failure|February 28, 2006
The year in heart failure 2005Barry M Massie, Thomas Force
Nature Reviews. Drug Discovery|February 2, 2011
Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomesThomas Force, Kyle L Kolaja
The Journal of Clinical Investigation|March 15, 2005
Protein kinase cascades in the regulation of cardiac hypertrophyGerald W Dorn, Thomas Force
Trends in Cardiovascular Medicine|April 10, 2007
Glycogen synthase kinase-3beta -- actively inhibiting hypertrophyRisto Kerkelä, Kathleen Woulfe, Thomas Force
Cell Cycle (Georgetown, Tex.)|October 13, 2006
Activation of beta-catenin signaling pathways by classical G-protein-coupled receptors: mechanisms and consequences in cycling and non-cycling cellsSergey P Shevtsov, Syed Haq, Thomas Force
Physiological Reviews|October 21, 2010
Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking taleBeth A Rose, Thomas Force, Yibin Wang
Journal of the American College of Cardiology|March 19, 2004
Highlights of the 2003 scientific sessions of the Heart Failure Society of America; Las Vegas, Nevada, September 21 to 24, 2003Peter Liu, Marvin A Konstam, Thomas Force
Journal of the American College of Cardiology|January 19, 2013
Cancer genetics and the cardiotoxicity of the therapeuticsHind Lal, Kyle L Kolaja, Thomas Force
Pageof 11